Kristin Karlsson

Om mig
Publikationer
CV
Populärvetenskap och samverkan

Om mig

- Sjukhusfysiker inom Strålbehandling på Karolinska Universitetssjukhuset
- Kliniskt verksam främst inom stereotaktisk strålbehandling (SBRT)
- Disputerade 2016 vid Karolinska Institutet inom ”Stereotactic body radiation therapy of lung tumours – Clinical and dosimetric aspects”
- Bedriver forskning inom SBRT, främst inom SBRT av centralt belägna lungtumörer samt inom osäkerheter vid behandling med SBRT
- Deltagare i Nordiska SBRT studiegruppen, ett samarbete inom klinisk forskning inom SBRT mellan kliniker i Sverige, Norge, Danmark och Finland
- Medlem i styrgruppen för Nationella SBRT gruppen, ett samarbete inom klinisk SBRT verksamhet mellan alla svenska SBRT kliniker
- Intresseområden: Stereotaktisk strålbehandling (SBRT), osäkerheter vid strålbehandling, biverkningar efter strålbehandling, utfallsmodelleringar

Artiklar

Article: RADIOTHERAPY AND ONCOLOGY. 2024;196:110318
Treatment planning and delivery practice of lung SBRT: Results of the 2022 ESTRO physics survey
Carver A; Scaggion A; Jurado-Bruggeman D; Blanck O; Dalqvist E; Giglioli FR; Jenko A; Karlsson K; Staykova V; Swinnnen A; Warren S; Mancosu P; Jornet N
Journal article: RADIOTHERAPY AND ONCOLOGY. 2024;194:s5099-s5103
1984: Cox-based prediction model of grade 5 bleeding after SBRT of ultra-centrally located lung tumors
Karlsson K; Rancati T; Lindberg S; Grozman V; Hoffmann L; Khalil A; Knap MM; Nielsen TB; Jeppesen SS; Kristiansen C; Ramberg C; Rogg LV; Drugge N; Nyman J; Josipovic M; Persson GF; Olofsson J; Bergström P; Rosenbrand H-O; Lödén B; Haraldsson A; Engelholm S; Billiet C; Lindberg K; Onjukka E
Journal article: RADIOTHERAPY AND ONCOLOGY. 2024;194:s4243-s4245
1238: Dosimetric impact of motion management techniques for radiotherapy of ventricular tachycardia
Mannerberg A; Nilsson MP; Edvardsson A; Karlsson K; van der Pals J; Ceberg S
Article: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2023;117(5):1222-1231
Expanded HILUS Trial: A Pooled Analysis of Risk Factors for Toxicity From Stereotactic Body Radiation Therapy of Central and Ultracentral Lung Tumors
Lindberg S; Grozman V; Karlsson K; Onjukka E; Lindback E; Al Jirf K; Lax I; Wersall P; Persson GF; Josipovic M; Khalil AA; Moller DS; Hoffmann L; Knap MM; Nyman J; Drugge N; Bergstrom P; Olofsson J; Rogg LV; Hagen RK; Froland A-S; Ramberg C; Kristiansen C; Jeppesen SS; Nielsen TB; Loden B; Rosenbrand H-O; Engelholm S; Haraldsson A; Billiet C; Lewensohn R; Lindberg K
Article: PHYSICS AND IMAGING IN RADIATION ONCOLOGY. 2023;28:100499
Abdominal compression as motion management for stereotactic radiotherapy of ventricular tachycardia
Mannerberg A; Nilsson MP; Edvardsson A; Karlsson K; Ceberg S
Journal article: RADIOTHERAPY AND ONCOLOGY. 2023;182:s1671-s1672
PO-1919 SBRT for central lung lesions: large biological delivered dose deviations for the bronchi
Lindbäck E; Al Jirf K; Hoffmann L; Møller DS; Karlsson K; Thomsen SN; Lindberg K; Khalil AA; Uzan J; Onjukka E
Journal article: RADIOTHERAPY AND ONCOLOGY. 2023;182:s608-s609
PD-0744 Abdominal compression as motion management for stereotactic radiotherapy of ventricular tachycardia?
Mannerberg A; Edvardsson A; Nilsson MP; Karlsson K; Ceberg S
Journal article: RADIOTHERAPY AND ONCOLOGY. 2023;182:s1692-s1693
PO-1937 Planning target margins for CBCT guided radiotherapy of the breast/thoracic wall and lymph nodes
Falk M; Hedman M; Bolin M; Falk J; Karlsson K; Onjukka E; Sorcini B; Gagliardi G
Article: PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS. 2021;88:53-64
Estimation of delivered dose to lung tumours considering setup uncertainties and breathing motion in a cohort of patients treated with stereotactic body radiation therapy
Karlsson K; Lax I; Lindback E; Grozman V; Lindberg K; Wersall P; Poludniowski G
Article: JOURNAL OF THORACIC ONCOLOGY. 2021;16(7):1200-1210
The HILUS-Trial-a Prospective Nordic Multicenter Phase 2 Study of Ultracentral Lung Tumors Treated With Stereotactic Body Radiotherapy
Lindberg K; Grozman V; Karlsson K; Lindberg S; Lax I; Wersall P; Persson GF; Josipovic M; Khalil AA; Moeller DS; Nyman J; Drugge N; Bergstrom P; Olofsson J; Rogg LV; Ramberg C; Kristiansen C; Jeppesen SS; Nielsen TB; Loden B; Rosenbrand H-O; Engelholm S; Haraldsson A; Billiet C; Lewensohn R
Article: ACTA ONCOLOGICA. 2017;56(9):1189-1196
Accuracy of the dose-shift approximation in estimating the delivered dose in SBRT of lung tumors considering setup errors and breathing motions
Karlsson K; Lax I; Lindback E; Poludniowski G
Article: ACTA ONCOLOGICA. 2015;54(8):1096-1104
Long-term results of a prospective phase II trial of medically inoperable stage I NSCLC treated with SBRT - the Nordic experience
Lindberg K; Nyman J; Kallskog VR; Hoyer M; Lund JA; Lax I; Wersall P; Karlsson K; Friesland S; Lewensohn R
Article: MEDICAL ONCOLOGY. 2012;29(5):3431-3439
A retrospective study of SBRT of metastases in patients with primary sarcoma
Stragliotto CL; Karlsson K; Lax I; Rutkowska E; Bergh J; Strander H; Blomgren H; Friesland S
Article: MEDICAL ONCOLOGY. 2011;28(4):958-965
Undetectable late hepatic sequelae after hypofractionated stereotactic radiotherapy for liver tumors
Gunven P; Jonas E; Blomgren H; Rutkowska E; Karlsson K; Lax I; Levitt S
Article: RADIOTHERAPY AND ONCOLOGY. 2011;101(2):260-266
Toxicity after reirradiation of pulmonary tumours with stereotactic body radiotherapy
Peulen H; Karlsson K; Lindberg K; Tullgren O; Baumann P; Lax I; Lewensohn R; Wersall P
Article: ACTA ONCOLOGICA. 2008;47(8):1578-1583
Stereotactic body radiotherapy of primary and metastatic renal lesions for patients with only one functioning kidney
Svedman C; Karlsson K; Rutkowska E; Sandstroem P; Blomgren H; Lax I; Wersaell P

Alla övriga publikationer

Letter: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2024;118(4):1144
Dose limits for brachial plexopathy
Onjukka E; Karlsson K; Lindberg K
Conference publication: RADIOTHERAPY AND ONCOLOGY. 2024;194:S5099-S5103
Cox-based prediction model of grade 5 bleeding after SBRT of ultra-centrally located lung tumors
Karlsson K; Rancati T; Lindberg S; Grozman V; Hoffmann L; Khalil A; Knap MM; Nielsen TB; Jeppesen SS; Kristiansen C; Ramberg C; Rogg LV; Drugge N; Nyman J; Josipovic M; Persson GF; Olofsson J; Bergstrom P; Rosenbrand H-O; Loden B; Haraldsson A; Engelholm S; Billiet C; Lindberg K; Onjukka E
Conference publication: RADIOTHERAPY AND ONCOLOGY. 2024;194:S4243-S4245
Dosimetric impact of motion management techniques for radiotherapy of ventricular tachycardia
Mannerberg A; Nilsson MP; Edvardsson A; Karlsson K; van der Pals J; Ceberg S
Conference publication: RADIOTHERAPY AND ONCOLOGY. 2023;182:S608-S609
Abdominal compression as motion management for stereotactic radiotherapy of ventricular tachycardia?
Mannerberg A; Edvardsson A; Nilsson MP; Karlsson K; Ceberg S
Conference publication: RADIOTHERAPY AND ONCOLOGY. 2023;182:S1671-S1672
SBRT for central lung lesions: large biological delivered dose deviations for the bronchi
Lindback E; Al Jirf K; Hoffmann L; Moller DS; Karlsson K; Thomsen SN; Lindberg K; Khalil AA; Uzan J; Onjukka E
Conference publication: RADIOTHERAPY AND ONCOLOGY. 2023;182:S1692-S1693
Planning target margins for CBCT guided radiotherapy of the breast/thoracic wall and lymph nodes
Falk M; Hedman M; Bolin M; Falk J; Karlsson K; Onjukka E; Sorcini B; Gagliardi G
Conference publication: RADIOTHERAPY AND ONCOLOGY. 2023;182:S2-S3
Pulmonary SBRT technical Practice: Results of the 2022 ESTRO survey
Scaggion A; Carver A; Karlsson K; Dalqvist E; Bruggeman DJ; Giglioli FR; Warren S; Staykova V; Jenko A; Swinnnen A; Blank O; Jornet N; Pietro P
Letter: ACTA ONCOLOGICA. 2022;61(7):869-873
Precision radiation of immune checkpoint therapy resistant melanoma metastases (PROMMEL study): study protocol for a phase II open-label multicenter trial
Backlund E; Yang M; Grozman V; Masucci G; Falkenius J; Eriksson H; Jovanovic B; Hammarlund K; Isacsson U; Radu C; Abel E; Karlsson K; Palanco Zamora R; Wersall P; Edback U; Wickstrom S; Darai Ramqvist E; Egyhazi Brage S; Kiessling R; Viktorsson K; Franzen B; Lewensohn R; Olofsson Bagge R; Ullenhag GJ; Ny L; Lindberg K; Helgadottir H
Letter: JOURNAL OF THORACIC ONCOLOGY. 2021;16(10):e81-e82
In Response to Rosenberg et al. "The Nordic-HILUS Trial: Ultracentral Lung SABR and a Narrow Therapeutic Window"
Lindberg K; Lax I; Karlsson K; Lewensohn R
Conference publication: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2017;99(2):E474
HILUS-Retrospective-A Retrospective Toxicity Analysis of Patients Treated with SBRT for Centrally Located Lung Lesions
Lindberg K; Karlsson K; Grozman V; Andersson A; Lax I; Ll PW; Lewensohn R
Conference publication: JOURNAL OF THORACIC ONCOLOGY. 2017;12(1):S340
The Nordic HILUS-Trial - First Report of a Phase II Trial of SBRT of Centrally Located Lung Tumors
Lindberg K; Bergstrom P; Brustugun OT; Engelholm S; Grozman V; Hoyer M; Karlsson K; Khalil A; Kristiansen C; Lax I; Loden B; Nyman J; Persson G; Rogg L; Wersall P; Lewensohn R
Thesis / dissertation: 2016
Stereotactic body radiation therapy of lung tumours : clinical and dosimetric aspects
Karlsson, Kristin
Published conference paper: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2013;87(3):590-595
Retrospective Cohort Study of Bronchial Doses and Radiation-Induced Atelectasis After Stereotactic Body Radiation Therapy of Lung Tumors Located Close to the Bronchial Tree
Karlsson K; Nyman J; Baumann P; Wersall P; Drugge N; Gagliardi G; Johansson K-A; Persson J-O; Rutkowska E; Tullgren O; Lax I
Conference publication: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2012;84(3):S32-S33
A Retrospective Study of Bronchial Doses and Radiation-induced Atelectasis After SBRT of Lung Tumors Located Close to the Bronchial Tree
Karlsson K; Nyman J; Baumann P; Wersall P; Gagliardi G; Johansson K; Persson J; Rutkowska E; Tullgren O; Lax I
Conference publication: RADIOTHERAPY AND ONCOLOGY. 2008;88:S377
SBRT TREATMENTS: REDUCTION OF DIAPHRAGMATIC AND TUMOUR EXCURSION BY MEANS OF FORCED SHALLOW BREATHING WITH ABDOMINAL COMPRESSION. ASSESSMENT BASED ON 2504 TREATED TUMOURS.
Karlsson K; Gagliardi G; Rutkowska E; Lax I

Anställningar

Anknuten till Forskning, Onkologi-Patologi, Karolinska Institutet, 2022-2025

Examina och utbildning

Medicine Doktorsexamen, Institutionen för onkologi-patologi, Karolinska Institutet, 2016

Om mig

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI